Ken Fisher Cogent Biosciences, Inc. Transaction History
Fisher Asset Management, LLC
- $229 Billion
- Q2 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 149,045 shares of COGT stock, worth $1.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
149,045
Previous 101,531
46.8%
Holding current value
$1.6 Million
Previous $682,000
84.16%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding COGT
# of Institutions
159Shares Held
114MCall Options Held
104KPut Options Held
163K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct10.5MShares$113 Million0.24% of portfolio
-
Commodore Capital LP New York, NY9.74MShares$105 Million7.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.26MShares$99.5 Million6.08% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$78.4 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$74.9 Million8.79% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $707M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...